Page last updated: 2024-10-22

acetazolamide and Asymptomatic Conditions

acetazolamide has been researched along with Asymptomatic Conditions in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kisilevsky, E1
Yu, E1
Margolin, E1
De Bortoli, M1
Maillet, A1
Skopinski, S1
Sassoust, G1
Constans, J1
Boulon, C1

Other Studies

2 other studies available for acetazolamide and Asymptomatic Conditions

ArticleYear
Asymptomatic Papilledema in a 64-Year-Old Man.
    JAMA ophthalmology, 2020, 08-01, Volume: 138, Issue:8

    Topics: Acetazolamide; Asymptomatic Diseases; Carbonic Anhydrase Inhibitors; Cerebral Veins; Humans; Intracr

2020
[Cerebral vasoreactivity: Concordance of breath holding test and acetazolamide injection in current practice: 20 cases of asymptomatic carotid artery stenosis].
    Journal de medecine vasculaire, 2017, Volume: 42, Issue:5

    Topics: Acetazolamide; Aged; Aged, 80 and over; Algorithms; Asymptomatic Diseases; Breath Holding; Carbonic

2017